摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-溴-2-(二乙基氨基)嘧啶 | 433684-23-2

中文名称
5-溴-2-(二乙基氨基)嘧啶
中文别名
5-溴-2-(二乙氨基)嘧啶
英文名称
5-bromo-N,N-diethylpyrimidin-2-amine
英文别名
2-(N,N-diethylamino)-5-bromopyrimidine
5-溴-2-(二乙基氨基)嘧啶化学式
CAS
433684-23-2
化学式
C8H12BrN3
mdl
——
分子量
230.107
InChiKey
AKTJBOBIMUJVHD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    29
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933599090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:ace1bd3339824d9bce1038ed7445b868
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Bromo-2-(diethylamino)pyrimidine
Synonyms: 5-Bromo-N,N-diethylpyrimidin-2-amine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-(diethylamino)pyrimidine
CAS number: 433684-23-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H12BrN3
Molecular weight: 230.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-溴-2-(二乙基氨基)嘧啶四(三苯基膦)钯正丁基锂caesium carbonate 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 反应 3.0h, 生成 2-(2-(diethylamino)pyrimidin-5-yl)-1,3-thiazol-4-amine
    参考文献:
    名称:
    [EN] INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
    [FR] INHIBITION DE CANAL IONIQUE À POTENTIEL DE RÉCEPTEUR TRANSITOIRE A1
    摘要:
    本发明涉及化合物的公式(I),或其药用可接受的盐或组合物,并其用于治疗疼痛、呼吸状况以及抑制瞬时受体电位Al离子通道(TRPA1)的方法。
    公开号:
    WO2016044792A1
  • 作为产物:
    描述:
    二乙胺5-溴-2-碘嘧啶乙醇 为溶剂, 反应 8.0h, 以95%的产率得到5-溴-2-(二乙基氨基)嘧啶
    参考文献:
    名称:
    Effect of single atom substitution in benzochalcogendiazole acceptors on the performance of ternary memory devices
    摘要:
    三种基于三苯硫族二唑衍生物的三元存储性能明显展示了单个原子取代对分子平面性、薄膜形貌和器件阈值电压的影响。
    DOI:
    10.1039/c5tc02274f
点击查看最新优质反应信息

文献信息

  • Preparation of Highly Reactive Pyridine- and Pyrimidine-Containing Diarylamine Antioxidants
    作者:Jason J. Hanthorn、Luca Valgimigli、Derek A. Pratt
    DOI:10.1021/jo301013c
    日期:2012.8.17
    produce a library of substituted heterocyclic diarylamines that we have used to provide further insight into the structure–reactivity relationships of these compounds as antioxidants (see the accompanying paper, DOI: 10.1021/jo301012x). The diarylamines were prepared in short, modular sequences from 2-aminopyridine and 2-aminopyrimidine wherein aminations of intermediate pyri(mi)dyl bromides and then
    我们最近报告了对开发新型二芳基胺自由基捕获抗氧化剂(汉索恩(JJ)等。J.上午 化学 Soc。 2012,134(8306-8309),其中我们证明了将环掺入二苯胺中可提供在H原子对过自由基的转移反应性与对单电子化的稳定性之间折衷的化合物。本文中,我们提供了与该报告相关的合成研究的详细信息,已对其进行了实质性扩展,以生成取代的杂环二芳基胺库,我们已使用该库进一步了解了这些化合物作为抗氧化剂的结构-反应性关系(请参阅随附的纸张,DOI:10.1021 / jo301012x)。简而言之,制备了二芳基胺 由2-氨基吡啶和2-氨基嘧啶组成的模块序列,其中中间体吡啶(mi)dyl化物的胺化以及然后Pd催化的胺与前体化物的交叉偶联反应是生成二芳基胺的关键步骤。发现交叉偶联反应在Pd(η3 -1-PHC 3 ħ 4)(η 5 -C 5 H ^ 5)作为前段催化剂,这给了比常规的Pd源,更高的产量2(DBA)3。
  • [EN] ANTIOXIDANTS AND METHODS TO MAXIMIZE PERFORMANCE<br/>[FR] ANTIOXYDANTS ET PROCÉDÉS POUR MAXIMISER LES PERFORMANCES
    申请人:UNIV OTTAWA
    公开号:WO2016123717A1
    公开(公告)日:2016-08-11
    A method of preventing or reducing the level of degradation of an organic substrate is described, wherein a composition is formed that includes the organic substrate together with an effective amount of a sacrificial base and a diarylamine antioxidant.
    本发明涉及一种防止或减少有机底物降解平的方法,其中形成了一种组合物,该组合物包括有机底物以及足够量的牺牲碱和二芳基胺抗氧化剂
  • Substituted Diarylamines and Use of Same as Antioxidants
    申请人:Pratt Derek A.
    公开号:US20140206585A1
    公开(公告)日:2014-07-24
    A compound of Formula I, Formula IA, Formula IB, or Formula II, or an acid or base addition salt thereof, and use of these compounds as antioxidants. In one embodiment, a compound of Formula II, wherein each of X, Y, and Z are independently a carbon or nitrogen atom; R 1 and R 2 are each independently a hydrogen or an electron donating group, but are not both hydrogen, and wherein R 1 , and R 2 are each bonded to a carbon atom in their own respective aryl ring.
    公式I、公式IA、公式IB或公式II的化合物或其酸或碱盐的混合物,并将这些化合物用作抗氧化剂。在一个实施例中,化合物为公式II,其中X、Y和Z分别独立地为原子;R1和R2分别独立地为或电子给体基团,但不是两个都是,并且R1和R2分别与它们自己的芳香环上的原子相结合。
  • BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF
    申请人:SUZHOU KEEN THERAPEUTICS CO., LTD.
    公开号:WO2023241620A1
    公开(公告)日:2023-12-21
    Provided are compounds, compositions, methods, use for preventing or treating various conditions, disorders or diseases. In some embodiments, a condition, disorder or disease is cancer.
    本文提供了用于预防或治疗各种病症、紊乱或疾病的化合物、组合物、方法和用途。在某些实施方案中,病症、紊乱或疾病是癌症。
  • Inhibiting the transient receptor potential A1 ion channel
    申请人:HYDRA BIOSCIENCES, INC.
    公开号:US10221177B2
    公开(公告)日:2019-03-05
    The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
    本发明涉及式(I)的药物化合物或其药学上可接受的盐或组合物,以及它们用于治疗疼痛、呼吸系统疾病以及抑制瞬态受体电位 A1 离子通道(TRPA1)的方法。
查看更多

同类化合物

(乙腈)二氯镍(II) (R)-(-)-α-甲基组胺二氢溴化物 (N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-3-氨基环丁烷甲腈盐酸盐 顺式-2-羟基甲基-1-甲基-1-环己胺 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺二盐酸盐 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷